Fisher Center scientists have created imaging technology that enables 3D visualisation of brain defects that cause Alzheimer's disease.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The technology, which has been funded by the Fisher Center for Alzheimer's Research Foundation, enables visualisation of amyloid plaques, as well as other alzheimer's hallmarks, such as tau, vasculature and microglia activation, in a large volume, in an entire mouse brain with the potential of application on frozen human brain samples.

Fisher Center for Alzheimer's Research Foundation president and CEO Kent Karosen said: "We are proud that the funding we provide has resulted in innovative, never before seen imaging of what causes Alzheimer's disease.

"The Fisher Center scientists are working diligently to better understand the cause and cure of the disease and with the ability to visualise the causes of Alzheimer's, we're one step closer to a cure."

"The Fisher Center scientists are working diligently to better understand the cause and cure of the disease and with the ability to visualise the causes of Alzheimer's, we're one step closer to a cure."

The scientists, by using the iDISCO visualisation method involving targeted molecular labeling, tissue clearing and light-sheet microscopy, gained access to intact mouse brains with Alzheimer's disease and studied in detail amyloid plaque content in five major brain regions, at different ages.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

They are now also able to co-visualise in 3D amyloid plaques together with two other parameters.

Volume imaging coupled with automated detection and mapping offers exact and fast quantification of plaques within the complete intact mouse brain, which is a faster and more economical alternative option to standard beta amyloid plaque labeling.

 Image: A possible 3D visualisation. Photo: courtesy of PRNewsFoto / Fisher Center for Alzheimer's.